Corrigendum to: Comparison of Induction Therapy in Non-high Risk Acute Promyelocytic Leukemia with Arsenic Trioxide or in Combination with ATRA Leukemia Research 66 (2018) 85–88

Ardeshir Ghavamzadeh,Mahdi Jalili,Sharbanoo Rostami,Marjan Yaghmaie,Leyla Sharifi Aliabadi,Seyed Asadollah Mousavi,Mohammad Vaezi,Hossein Kamranzadeh Fumani,Mohammad Jahani,Kamran Alimoghaddam

Leukemia Research（2018）

引用 1|浏览11

暂无评分

摘要

•The arsenic trioxide plus ATRA is compared against single ATO therapy in APL.•The result showed a significant decrease in relapse with combination therapy.•The ATO plus ATRA must considered as first line therapy in non-high risk patients.

查看译文

关键词

Acute promyelocytic leukemia,Arsenic trioxide,ATRA,Combination therapy

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要